MedPath

The comparison of effectiveness of Cinal-f and Gonal-f in IVF cycles in patients referring to vali-e asr reproductive health research center

Phase 3
Conditions
Female Infertility.
Female infertility
Registration Number
IRCT201011155181N1
Lead Sponsor
Cinajen Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

Age less than35 years
FSH in the 2 date of cycle less than or equal to8.3
regularity of menses
long protocol for suppression of hypothesis

Exclusion Criteria

smoking
history of any operation of ovary
sensitivity to Gonal–f or Cinal-f
Abnormal hormonal profiles
History of ovarian hyper stimulation
Tumors of sex organs
Uncontrolled insufficiency of thyroid or adrenal

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of metaphase II oocytes. Timepoint: The oocyte retrieval day. Method of measurement: Based on embryologist assessment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath